Article
[Plasminogen activator inhibitor type 1 activity in women with unexplained very early recurrent pregnancy loss].
Akusherstvo i ginekologiia - 1 Jan 2010
Ivanov P, Komsa-Penkova R, Ivanov I, Konova E, Kovacheva K, Simeonova M, Tanchev S
Abstract excerpt
The aim of the study was to assess the independent role of polymorphism 4G/5G (PL 4G/5G)--genotype 4G/4G in plasminogen activator inhibitor type 1 (PAI-1) in the development of very early recurrent pregnancy loss (RPL)--before 10 weeks of gestation of pregnancy. The polymorphism 4G/5G as well as Factor V Leiden (FVL), prothrombin (FII) gene mutation 20210 G > A and polymorphism 677 C > T in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
